Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 17
1985 11
1986 20
1987 49
1988 25
1989 47
1990 35
1991 48
1992 50
1993 53
1994 69
1995 74
1996 64
1997 85
1998 80
1999 77
2000 125
2001 114
2002 106
2003 138
2004 93
2005 115
2006 101
2007 122
2008 165
2009 122
2010 133
2011 123
2012 110
2013 116
2014 83
2015 94
2016 73
2017 64
2018 79
2019 69
2020 75
2021 90
2022 69
2023 67
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

3,061 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean scovill (87 results)?
The HOPE Study (Heart Outcomes Prevention Evaluation).
Sleight P. Sleight P. J Renin Angiotensin Aldosterone Syst. 2000 Mar;1(1):18-20. doi: 10.3317/jraas.2000.002. J Renin Angiotensin Aldosterone Syst. 2000. PMID: 11967789 Free article. Review.
As a result, despite a history of hypertension in nearly 50% of patients, blood pressure (BP) at baseline was normal and the reduction in BP attributable to ramipril modest (a fall of 3-4 mmHg systolic BP and 1-2 mmHg diastolic). The trial was stopped early on the advice o …
As a result, despite a history of hypertension in nearly 50% of patients, blood pressure (BP) at baseline was normal and the reduction in BP …
Clinical pharmacokinetics of ramipril.
Meisel S, Shamiss A, Rosenthal T. Meisel S, et al. Clin Pharmacokinet. 1994 Jan;26(1):7-15. doi: 10.2165/00003088-199426010-00002. Clin Pharmacokinet. 1994. PMID: 8137599 Review.
Ramipril is a prodrug that undergoes de-esterification in the liver to form ramiprilat, its active metabolite. ...After absorption from the gastrointestinal tract, rapid hydrolysis of ramipril occurs in the liver. In the therapeutic concentration range, protein bind …
Ramipril is a prodrug that undergoes de-esterification in the liver to form ramiprilat, its active metabolite. ...After absorption fr …
Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.
Dinicolantonio JJ, Lavie CJ, O'Keefe JH. Dinicolantonio JJ, et al. Postgrad Med. 2013 Jul;125(4):154-68. doi: 10.3810/pgm.2013.07.2687. Postgrad Med. 2013. PMID: 23933903 Review.
Moreover, there is a large amount of evidence to suggest that perindopril therapy may reduce cardiovascular event rates in patients, yet perindopril is rarely prescribed in the United States. Ramipril is another ACE inhibitor with both a favorable clinical profile and impr …
Moreover, there is a large amount of evidence to suggest that perindopril therapy may reduce cardiovascular event rates in patients, yet per …
Ramipril.
Smith WH, Ball SG. Smith WH, et al. Int J Clin Pract. 2000 May;54(4):255-60. Int J Clin Pract. 2000. PMID: 10912316 Review.
Ramipril is a long-acting, lipophylic angiotensin converting enzyme inhibitor, its principle action is to inhibit the conversion of angiotensin I to the active angiotensin II. ...This article concentrates on reviewing the evidence supporting ramipril's use in these …
Ramipril is a long-acting, lipophylic angiotensin converting enzyme inhibitor, its principle action is to inhibit the conversion of a …
Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.
[No authors listed] [No authors listed] Lancet. 1993 Oct 2;342(8875):821-8. Lancet. 1993. PMID: 8104270 Clinical Trial.
Patients were randomly allocated to double-blind treatment with either placebo (992 patients) or ramipril (1014 patients) on day 3 to day 10 after AMI (day 1). Patients with severe heart failure resistant to conventional therapy, in whom the attending physician considered …
Patients were randomly allocated to double-blind treatment with either placebo (992 patients) or ramipril (1014 patients) on day 3 to …
Preventing stroke.
Schrader J, Lüders S. Schrader J, et al. BMJ. 2002 Mar 23;324(7339):687-8. doi: 10.1136/bmj.324.7339.687. BMJ. 2002. PMID: 11909769 Free PMC article. No abstract available.
Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition.
Lytvyn Y, Kimura K, Peter N, Lai V, Tse J, Cham L, Perkins BA, Soleymanlou N, Cherney DZI. Lytvyn Y, et al. Circulation. 2022 Aug 9;146(6):450-462. doi: 10.1161/CIRCULATIONAHA.122.059150. Epub 2022 Jul 11. Circulation. 2022. PMID: 35862082 Free PMC article. Clinical Trial.
Measurements were obtained after each of the 6 treatment phases over 19 weeks: (1) baseline without treatment, (2) 4-week run-in with ramipril treatment alone, (3) 4-week combined empagliflozin-ramipril treatment, (4) a 4-week washout, (5) 4-week combined placebo- …
Measurements were obtained after each of the 6 treatment phases over 19 weeks: (1) baseline without treatment, (2) 4-week run-in with ram …
The HOPE study.
Bargout R. Bargout R. Cleve Clin J Med. 2000 Jun;67(6):452. Cleve Clin J Med. 2000. PMID: 10860230 Free article. No abstract available.
Aliskiren versus ramipril in hypertension.
Verdecchia P, Angeli F, Mazzotta G, Martire P, Garofoli M, Gentile G, Reboldi G. Verdecchia P, et al. Ther Adv Cardiovasc Dis. 2010 Jun;4(3):193-200. doi: 10.1177/1753944710369682. Epub 2010 Apr 23. Ther Adv Cardiovasc Dis. 2010. PMID: 20418269 Free article. Review.
Over the past 2 years, three studies have been published which directly compared aliskiren with ramipril, in patients with hypertension. We made a pooled analysis of these studies. ...In each individual study, systolic blood pressure (BP) was slightly lower with aliskiren. …
Over the past 2 years, three studies have been published which directly compared aliskiren with ramipril, in patients with hypertensi …
Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Huang DQ, Ajmera V, Tomaszewski C, LaFree A, Bettencourt R, Thompson WK, Smith DM, Malhotra A, Mehta RL, Tolia V, Yin J, Insel PA, Leachman S, Jung J, Collier S, Richards L, Woods K, Amangurbanova M, Bhatt A, Zhang X, Penciu OM, Zarich S, Retta T, Harkins MS, Teixeira JP, Chinnock B, Utay NS, Lake JE, Loomba R. Huang DQ, et al. Adv Ther. 2023 Nov;40(11):4805-4816. doi: 10.1007/s12325-023-02618-7. Epub 2023 Aug 24. Adv Ther. 2023. PMID: 37615850 Free PMC article. Clinical Trial.
Participants were randomly assigned to daily ramipril 2.5 mg or placebo orally in a 2:1 ratio, using permuted block randomization. ...Two participants in the ramipril group required ICU admission and one died, compared with none in the placebo group. ...
Participants were randomly assigned to daily ramipril 2.5 mg or placebo orally in a 2:1 ratio, using permuted block randomization. .. …
3,061 results